SEOM clinical guidelines in early-stage breast cancer 2015-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SEOM clinical guidelines in early-stage breast cancer 2015

Published:2015-10-26 Issue:12 Volume:17 Page:939-945
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Garcia-Saenz J. A.,Bermejo B.,Estevez L. G.,Palomo A. G.,Gonzalez-Farre X.,Margeli M.,Pernas S.,Servitja S.,Rodriguez C. A.,Ciruelos E.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-015-1427-3.pdf

Reference57 articles.

1. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx . Accessed 26 Sept 2015.

2. Cho SH, Jeon J, Kim SI. Personalized medicine in breast cancer: a systematic review. J Breast Cancer. 2012;15:265–72.

3. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet. 2012;379:432–44.

4. Polley MY, Leung SC, McShane LM, Gao D, Jc Hugh, Mastropasqua MG, et al. An international Ki67 reproducibility study. J Natl Cancer Inst. 2013;105:1897–906.

5. Menezes GL, Knuttel F, Stehouwer M. Magnetic resonance imaging in breast cancer: a literature review and future perspectives. World J Clin Oncol. 2014;5:61–70.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA SEMA3B‐AS1 suppresses the tumor‐initiating characteristics of triple negative breast cancer via engaging in MLL4‐mediated H3K4 trimethylation;Molecular Carcinogenesis;2023-11-17

2. Assessing the methodological strengths and limitations of the Spanish Society of Medical Oncology (SEOM) guidelines: a critical appraisal using AGREE II and AGREE-REX tool;Clinical and Translational Oncology;2023-06-27

3. Benefits of neoadjuvant therapy compared with adjuvant chemotherapy for the survival of patients with HER2-positive breast cancer: A retrospective cohort study at FUSCC;The Breast;2022-06

4. Review of imaging techniques for evaluating morphological and functional responses to the treatment of bone metastases in prostate and breast cancer;Clinical and Translational Oncology;2022-02-13

5. Mechanisms of Drug Resistance and Use of Nanoparticle Delivery to Overcome Resistance in Breast Cancers;Advances in Experimental Medicine and Biology;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3